Your location:Home page > Program
Rongrong Li
Share on:
WuXi AppTec (Suzhou) Co., Ltd

Common on-target and off-target pathology findings associated with ADC drugs, highlighting key tissue-specific toxicities, mechanisms of action, and strategies for risk assessment and mitigation in preclinical development.


10

0

0

Date Time Local Time Room Forum Session Role Topic
2025-10-15 11:20-11:40 2025-10-15,11:20-11:40Room 4 - Guohua Hall Special Seminars

WuXi AppTec Seminar: Changing Drug Development Landscape With New Modalities Such as Antibody Drug Conjugates (ADC)

Speaker Pathology, off-target and on-target effects